Director, Value Communication (Hybrid) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Insulet Corporation · 1 day ago

Director, Value Communication (Hybrid)

Insulet Corporation is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions. The Director, U.S. Value Communication, is responsible for translating enterprise-level value strategies into actionable payer engagement tools and access plans, focusing on optimal coverage, reimbursement, and patient access strategies.

Health CareMedicalMedical Device
check
Comp. & Benefits

Responsibilities

Lead the development and implementation of U.S. value communication across commercial and government channels (PBMs, MCOs, Medicare, Medicaid, IDNs)
Translate global and enterprise-level value propositions into digestible, field-ready messaging and tools tailored to payer priorities
Partner with Account Teams to refine access tactics based on real-world customer feedback and evolving market dynamics
Anticipates internal and external business challenges, vendor and/or regulatory issues, recommends process, product, or service improvements
Solves significant, unique and complex problems that have a broad impact on the business
Accountable for results, which may impact the function
Creates formal networks involving coordination among groups and persuades diverse stakeholders/audiences, providing leadership and understanding of wider business
Collaborate with field teams to understand payer pain points and ensure access strategies resonate with customer needs
Develop and deploy training, messaging platforms, and objection-handling guides that empower Account teams to deliver impactful payer conversations
Design and execute pull-through campaigns that convert formulary positions into prescribing behavior by creating tools that educate HCPs and their staff on coverage, affordability, and access pathways
Partner with Sales and Field Access teams to align messaging and tactics that drive brand uptake and overcome access barriers
Leverage CRM platforms (e.g., Salesforce) to deliver approved payer messaging and track field execution effectiveness
Develop content that simplifies complex coverage information into digestible formats for HCPs and field teams
Monitor and respond to perceptions in the field, such as outdated beliefs about coverage or prior authorization hurdles, and proactively correct them through targeted messaging
Work closely with Global Market Access, HCP Marketing, Advocacy, Government Affairs, Legal, and the Growth team to align execution with broader business goals
Coordinate with Global Market Access team to ensure seamless handoff and localization of upstream strategies
Stay abreast of legislative, regulatory, and policy changes impacting U.S. access and reimbursement
Inform internal stakeholders of emerging trends and implications for Value Communication and execution

Qualification

Payer strategyMarket accessReimbursement rolesField-ready messagingU.S. payer landscapeCross-functional leadershipAdvanced degreeCustomer engagementPolicy monitoringCollaboration skills

Required

Bachelor's degree required; advanced degree (MBA, MPH, PharmD)
15+ years in pharmaceuticals, with deep experience in market access, payer strategy, or reimbursement roles
Proven ability to lead cross-functional teams and influence senior stakeholders
Strong understanding of the U.S. payer landscape and pharmacy reimbursement methodologies
Demonstrated success in developing field-ready messaging and tools that resonate with payers
Hands-on experience working with customers—comfortable navigating complex payer environments

Preferred

Advanced degree (MBA, MPH, PharmD)

Benefits

Medical, dental, and vision insurance
401(k) with company match
Paid time off (PTO)
And additional employee wellness programs

Company

Insulet Corporation

company-logo
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform.

Funding

Current Stage
Public Company
Total Funding
$629.5M
Key Investors
DeerfieldOrbiMedAlta Partners
2025-03-18Post Ipo Debt· $450M
2009-03-16Post Ipo Debt· $60M
2007-05-15IPO

Leadership Team

leader-logo
Ashley McEvoy
President & Chief Executive Officer
linkedin
leader-logo
Ana Maria Chadwick
Chief Financial Officer
linkedin
Company data provided by crunchbase